Fundraising FoxColumbus Venture Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Arthex Biotecharthexbiotech.comin𝕏Series B · May 2023 · $46M✓ verified
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs.
AI & Machine LearningBiotechMedical Devices
Beatriz Llamusí(Chief Scientific Officer & Co-Founder)in
PartnerJose Mesa· solo GP
Co-investorsHadean VenturesSound BioventuresBpifranceAdBio partnersInvivo Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.